Paysign, Inc. (NASDAQ:PAYS – Get Free Report) shares hit a new 52-week high during trading on Friday. The stock traded as high as $14.93 and last traded at $14.36, with a volume of 2537830 shares traded. The stock had previously closed at $13.48.
Wall Street Analysts Forecast Growth
PAYS has been the topic of a number of analyst reports. Wall Street Zen lowered Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Weiss Ratings raised Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, July 29th. Lake Street Capital lifted their price objective on Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a research note on Tuesday, September 15th. Barrington Research set a $15.00 target price on Paysign in a report on Tuesday, August 11th. Finally, DA Davidson increased their target price on shares of Paysign from $12.00 to $15.00 and gave the company a “buy” rating in a research report on Wednesday. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $15.00.
Check Out Our Latest Report on PAYS
Paysign Stock Performance
Paysign (NASDAQ:PAYS – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.05. Paysign had a net margin of 15.67% and a return on equity of 30.13%. The company had revenue of $28.25 million for the quarter, compared to the consensus estimate of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. On average, sell-side analysts anticipate that Paysign, Inc. will post 0.58 earnings per share for the current year.
Insider Buying and Selling at Paysign
In related news, CFO Jeffery Baker sold 35,000 shares of the firm’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $12.62, for a total value of $441,700.00. Following the transaction, the chief financial officer owned 542,171 shares of the company’s stock, valued at approximately $6,842,198.02. This trade represents a 6.06% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Joan M. Herman sold 38,900 shares of the firm’s stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $11.74, for a total transaction of $456,686.00. Following the completion of the transaction, the executive vice president directly owned 609,421 shares in the company, valued at approximately $7,154,602.54. The trade was a 6.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 444,904 shares of company stock valued at $5,328,124 over the last three months. Corporate insiders own 24.50% of the company’s stock.
Institutional Trading of Paysign
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PAYS. Tidal Investments LLC purchased a new stake in shares of Paysign in the second quarter worth approximately $121,000. Connective Capital Management LLC purchased a new position in shares of Paysign during the second quarter valued at approximately $327,000. Corient Private Wealth LP grew its holdings in Paysign by 69.8% during the second quarter. Corient Private Wealth LP now owns 30,159 shares of the company’s stock worth $247,000 after buying an additional 12,396 shares in the last quarter. Punch & Associates Investment Management Inc. bought a new stake in Paysign during the second quarter worth $16,983,000. Finally, Bank of America Corp DE bought a new stake in Paysign during the second quarter worth $335,000. 25.89% of the stock is owned by institutional investors.
About Paysign
Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.
The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.
Further Reading
- Five stocks we like better than Paysign
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.
